Skip to content
10-Q

Quarterly Report

ENZO BIOCHEM, INC.

0001213900-25-054828

← back to feed
Filed
Jun 16, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Jun 10, 2025 52.4M sh
Shares Diluted Q3 2025 · Apr 30, 2025 52.4K sh
Shares Diluted Q3 2025 · Apr 30, 2025 52.32K sh
Shares Diluted Q3 2025 · Apr 30, 2024 51.21K sh
Shares Diluted Q3 2025 · Apr 30, 2024 50.63K sh
Dividends Paid Q3 2025 · Apr 30, 2025 $5.32M
Operating Cash Flow Q3 2025 · Apr 30, 2025 −$14.24M
Operating Cash Flow Q3 2025 · Apr 30, 2024 −$25.17M
Long Term Debt Q3 2025 · Apr 30, 2025 $129K
Long Term Debt Q3 2025 · Jul 31, 2024 $189K
Cash And Equivalents Q3 2025 · Apr 30, 2025 $36.69M
Cash And Equivalents Q3 2025 · Jul 31, 2024 $52.37M
Stockholders Equity Q3 2025 · Apr 30, 2025 $43.4M
Stockholders Equity Q3 2025 · Dec 31, 2024 $46.62M
Stockholders Equity Q3 2025 · Jul 31, 2024 $56.11M
Stockholders Equity Q3 2025 · Apr 30, 2024 $69.03M
Stockholders Equity Q3 2025 · Dec 31, 2023 $70.78M
Stockholders Equity Q3 2025 · Jul 31, 2023 $78.46M
Current Liabilities Q3 2025 · Apr 30, 2025 $17.01M
Current Liabilities Q3 2025 · Jul 31, 2024 $24.79M
Total Liabilities Q3 2025 · Apr 30, 2025 $20.12M
Total Liabilities Q3 2025 · Jul 31, 2024 $29.65M
Current Assets Q3 2025 · Apr 30, 2025 $48.28M
Current Assets Q3 2025 · Jul 31, 2024 $70.03M
Total Assets Q3 2025 · Apr 30, 2025 $63.52M
Total Assets Q3 2025 · Jul 31, 2024 $85.76M
Eps Diluted Q3 2025 · Apr 30, 2025 −$0.05
Eps Diluted Q3 2025 · Apr 30, 2025 −$0.15
Eps Diluted Q3 2025 · Apr 30, 2024 −$0.06
Eps Diluted Q3 2025 · Apr 30, 2024 −$0.25
Eps Basic Q3 2025 · Apr 30, 2025 −$0.05
Eps Basic Q3 2025 · Apr 30, 2025 −$0.15
Eps Basic Q3 2025 · Apr 30, 2024 −$0.06
Eps Basic Q3 2025 · Apr 30, 2024 −$0.25
Sga Expense Q3 2025 · Apr 30, 2025 $4.9M
Sga Expense Q3 2025 · Apr 30, 2025 $14.35M
Sga Expense Q3 2025 · Apr 30, 2024 $4.48M
Sga Expense Q3 2025 · Apr 30, 2024 $16.55M
Rd Expense Q3 2025 · Apr 30, 2025 $504K
Rd Expense Q3 2025 · Apr 30, 2025 $1.55M
Rd Expense Q3 2025 · Apr 30, 2024 $605K
Rd Expense Q3 2025 · Apr 30, 2024 $2.04M
Net Income Q3 2025 · Apr 30, 2025 −$2.79M
Net Income Q3 2025 · Apr 30, 2025 −$2.79M
Net Income Q3 2025 · Apr 30, 2025 −$7.7M
Net Income Q3 2025 · Apr 30, 2024 −$3.02M
Net Income Q3 2025 · Apr 30, 2024 −$3.02M
Net Income Q3 2025 · Apr 30, 2024 −$12.7M
Operating Income Q3 2025 · Apr 30, 2025 −$3.39M
Operating Income Q3 2025 · Apr 30, 2025 −$8.62M
Operating Income Q3 2025 · Apr 30, 2024 −$2.04M
Operating Income Q3 2025 · Apr 30, 2024 −$9.7M
Cost Of Revenue Q3 2025 · Apr 30, 2025 $3.76M
Cost Of Revenue Q3 2025 · Apr 30, 2025 $10.99M
Cost Of Revenue Q3 2025 · Apr 30, 2024 $4.29M
Cost Of Revenue Q3 2025 · Apr 30, 2024 $12.97M
Revenue Q3 2025 · Apr 30, 2025 $6.4M
Revenue Q3 2025 · Apr 30, 2025 $19.95M
Revenue Q3 2025 · Apr 30, 2024 $8.02M
Revenue Q3 2025 · Apr 30, 2024 $24.38M